Oral phenylbutyrate for treatment of human 4-repeat tauopathies

EP4661859A1Pending Publication Date: 2025-12-17LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN IN VERTRETUNG DES FREISTAATES BAYERN
0 Cites 0 Cited by

Patent Information

Application Number
EP2024704194
Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-02-10
Filing Date
2024-02-09
Publication Date
2025-12-17

Smart Images

  • Figure IMGF000007_0001
    Figure IMGF000007_0001
  • Figure IMGF000008_0001
    Figure IMGF000008_0001
  • Figure IMGF000011_0001
    Figure IMGF000011_0001
Patent Text Reader

Abstract

The present invention relates to the treatment or prevention of a 4-repeat tauopathy by orally administering phenylbutyrate or a pharmaceutically acceptable salt thereof or a prodrug thereof or a solvate thereof.
Need to check novelty before this filing date? Find Prior Art